NCT03757650View on ClinicalTrials.gov

THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY

PHASE4CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

November 1, 2020

Study Completion Date

February 1, 2021

Conditions
Helicobacter Pylori InfectionObesity, Morbid
Interventions
DRUG

Bismuth Subsalicylate

omeprazole 2x1) + clarithromycin 2x500 mg + amoxicilline 2x1000 mg + Bismuth Subsalicylate 2x1

Trial Locations (1)

34734

Fatih Sultan Mehmet Research and Training Hospital, Istanbul

All Listed Sponsors
lead

Fatih Sultan Mehmet Training and Research Hospital

OTHER

NCT03757650 - THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY | Biotech Hunter | Biotech Hunter